Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Oct. 23, 2021 |
Aug. 10, 2021 |
Dec. 31, 2020 |
Oct. 23, 2020 |
Dec. 31, 2019 |
|---|---|---|---|---|---|---|
| Business Acquisition [Line Items] | ||||||
| Short term investments | $ 1,800 | |||||
| Accounts receivable | 222 | |||||
| Inventory | 82 | |||||
| Prepaid and other current assets | 379 | |||||
| Definite-lived intangible asset | 10,990 | |||||
| Total assets acquired | 13,473 | |||||
| Accounts payable | (805) | |||||
| Accrued expenses and other current liabilities | (43) | |||||
| Deferred revenue | (2,391) | |||||
| Note payable | (81) | |||||
| Deferred tax liability | (1,925) | |||||
| Total liabilities assumed | (5,245) | |||||
| Net identifiable assets acquired | 8,228 | |||||
| Goodwill | $ 5,709 | $ 901,000 | 4,446 | $ 901 | ||
| Total consideration | $ 12,674 | |||||
| CPM acquisition [Member] | ||||||
| Business Acquisition [Line Items] | ||||||
| Definite-lived intangible asset | $ 1,307 | |||||
| Total assets acquired | 1,599 | |||||
| Deferred tax liability | (362) | |||||
| Total liabilities assumed | (362) | |||||
| Net identifiable assets acquired | 1,237 | |||||
| Goodwill | 1,263 | |||||
| Total consideration | 2,500 | |||||
| Clinical lab material | 180 | |||||
| Lab equipment | $ 112 |
| X | ||||||||||
- Definition Business combination recognized identifiable assets acquired and liabilities assumed current liabilities . No definition available.
|
| X | ||||||||||
- Definition Business combination recognized identifiable assets acquired and liabilities assumed current liabilities note payable. No definition available.
|
| X | ||||||||||
- Definition Business combination recognized identifiable assets acquired and liabilities assumed in short term investments. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of assets acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of inventory recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of property, plant, and equipment recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|